Mingde Biotechnology: Plans to acquire 100% equity of Wuhan Bikaier in cash, the transaction is still uncertain.

Mingde Bio announced that the company plans to cash acquire 100% equity of Wuhan Bikay Medical Supplies Co., Ltd. held by Blue Sail Medical, which is expected to constitute a major asset restructuring. The transaction does not constitute a reorganization of the listing, related party transactions, or a change in controlling rights. The acquisition intent was disclosed on December 31, 2025. As of the announcement date, the relevant parties have not signed a formal agreement. The company is progressing with audits, evaluations, and other work, and there is uncertainty in the transaction. Any progress will be disclosed in a timely manner.